German Cancer Aid

German Cancer Aid
Sir James · CC BY-SA 3.0 · source
Name	German Cancer Aid
Native name	Deutsche Krebshilfe
Founded	1974
Founder	Hildegard Hamm-Brücher?
Headquarters	Bonn
Focus	Cancer research, patient support, prevention

German Cancer Aid German Cancer Aid is a major German non-profit organization dedicated to cancer control, cancer research funding, patient advocacy, and public education. Founded in the 1970s, it operates nationally from Bonn and engages with institutions across Berlin, Munich, Hamburg, Cologne, and international partners in Geneva and Brussels. Its work intersects with hospitals such as Charité – Universitätsmedizin Berlin, research centers like the German Cancer Research Center, and policy actors in the Bundestag.

History

The organization's roots trace to the early 1970s when figures in German public life and health policy sought to address rising cancer incidence through coordinated action involving institutions such as Robert Koch Institute, Max Planck Society, Helmholtz Association, and regional bodies like the Landtag of North Rhine-Westphalia. Early supporters included prominent politicians and philanthropists active alongside entities such as Deutsche Forschungsgemeinschaft, BMBF, European Commission, and advocacy groups like German Medical Association. Over decades the organization developed programs in consultation with university clinics at Heidelberg University Hospital, University Hospital Hamburg-Eppendorf, and LMU Klinikum at Ludwig Maximilian University of Munich. Milestones included collaborations with the World Health Organization, partnerships with the European Cancer Organisation, and influence on legislation debated in the Bundesrat.

Mission and Objectives

The stated mission emphasizes reducing cancer morbidity and mortality, supporting patients, and improving care quality through funding, information, and advocacy. Objectives align with initiatives led by bodies such as the European Commission's cancer plan, models from the National Institutes of Health, and recommendations by the Union for International Cancer Control. Priorities include early detection programs advised by experts from University College London, translational research coordination with the Francis Crick Institute, and patient rights promoted alongside groups like European Patients' Forum.

Organization and Governance

Governance includes a board of trustees and an executive management structure interacting with advisory panels composed of clinicians from Charité – Universitätsmedizin Berlin, scientists from the German Cancer Research Center, ethicists with ties to Humboldt University of Berlin, and legal experts familiar with rulings from the Federal Constitutional Court of Germany. The organization consults with professional societies such as the German Society of Hematology and Medical Oncology, the German Society for Radiation Oncology, and the German Society for Surgery. Regional offices coordinate with municipal authorities in cities like Dortmund and Stuttgart and health insurers including AOK and Techniker Krankenkasse.

Funding and Activities

Funding derives from donations, legacies, corporate partnerships, and grants administered in cooperation with foundations such as the Robert Bosch Stiftung, the Körber Foundation, and the Evangelical Church in Germany. Activities span patient counseling services akin to those at Hannover Medical School, funding of clinical infrastructure at centers such as the University Hospital Freiburg, and support for public campaigns parallel to initiatives by World Cancer Research Fund International. The organization also issues awards comparable to recognitions from the European Society for Medical Oncology and facilitates symposiums in venues like Deutsche Messe.

Research and Grants

Grant programs prioritize translational projects at institutions such as Heidelberg University, the Technical University of Munich, and collaborative networks including the German Cancer Consortium. Funding supports investigators who publish in journals like The Lancet Oncology and Nature Medicine and partners with consortia formed by universities such as University of Cologne and Friedrich Schiller University Jena. The grants often intersect with EU research instruments like Horizon 2020 and collaborations with agencies including European Molecular Biology Laboratory and the European Research Council. The organization has funded clinical trials conducted at centers including Charité and University Hospital Essen.

Public Education and Prevention Programs

Prevention campaigns target risk factors alongside initiatives by World Health Organization and European Public Health Alliance, promoting screening programs referenced by the European Commission and modeled after campaigns in United Kingdom and Netherlands. Educational resources are developed in partnership with cancer registries such as the Saarland Cancer Registry and academic public health departments at University of Bielefeld and Hannover Medical School. Outreach involves collaborations with media outlets in Frankfurt and public figures who have worked with organizations like German Red Cross.

Partnerships and International Involvement

International engagement includes partnerships with the International Agency for Research on Cancer, the Union for International Cancer Control, and bilateral collaborations with institutions in United States, United Kingdom, France, Japan, and Canada. The organization participates in EU policy dialogues in Brussels and global initiatives convened by the World Health Organization in Geneva. Collaborative networks include ties to the European Cancer Organisation, research linkages with the Johns Hopkins Hospital, and cooperative projects with the Institut Gustave Roussy.

Category:Medical and health organizations based in Germany